RGPD3
Basic information
Region (hg38): 2:106391290-106468413
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RGPD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 146 | 15 | 161 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 146 | 19 | 0 |
Variants in RGPD3
This is a list of pathogenic ClinVar variants found in the RGPD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-106413095-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
2-106413119-A-G | not specified | Likely benign (Nov 16, 2021) | ||
2-106413137-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
2-106413143-A-G | not specified | Uncertain significance (Nov 18, 2023) | ||
2-106413270-T-C | not specified | Uncertain significance (May 10, 2024) | ||
2-106415860-T-C | not specified | Uncertain significance (Aug 28, 2021) | ||
2-106415863-A-G | not specified | Uncertain significance (Jan 06, 2023) | ||
2-106415878-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
2-106415894-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
2-106415903-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
2-106415971-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
2-106415974-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
2-106415975-A-T | not specified | Uncertain significance (Oct 22, 2021) | ||
2-106415978-A-G | not specified | Uncertain significance (Sep 29, 2022) | ||
2-106423081-T-G | not specified | Uncertain significance (Nov 09, 2022) | ||
2-106423087-G-A | not specified | Uncertain significance (Jun 02, 2024) | ||
2-106423130-A-C | not specified | Uncertain significance (Feb 28, 2024) | ||
2-106423139-T-C | not specified | Uncertain significance (Jun 22, 2021) | ||
2-106423140-A-T | not specified | Uncertain significance (Dec 19, 2023) | ||
2-106423153-G-A | not specified | Uncertain significance (May 02, 2024) | ||
2-106423154-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
2-106423208-A-C | not specified | Uncertain significance (Dec 21, 2023) | ||
2-106423209-A-T | not specified | Uncertain significance (Feb 14, 2023) | ||
2-106423210-C-G | not specified | Uncertain significance (Jan 31, 2023) | ||
2-106423289-A-G | not specified | Uncertain significance (Mar 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RGPD3 | protein_coding | protein_coding | ENST00000409886 | 23 | 63387 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.46e-50 | 2.73e-11 | 123389 | 72 | 2250 | 125711 | 0.00928 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -3.42 | 772 | 547 | 1.41 | 0.0000274 | 11240 |
Missense in Polyphen | 166 | 117.88 | 1.4082 | 2380 | ||
Synonymous | -2.65 | 254 | 206 | 1.23 | 0.0000115 | 3245 |
Loss of Function | -2.53 | 65 | 46.4 | 1.40 | 0.00000235 | 1057 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0428 | 0.0416 |
Ashkenazi Jewish | 0.000715 | 0.000695 |
East Asian | 0.00447 | 0.00436 |
Finnish | 0.00265 | 0.00254 |
European (Non-Finnish) | 0.00748 | 0.00726 |
Middle Eastern | 0.00447 | 0.00436 |
South Asian | 0.0100 | 0.00856 |
Other | 0.00830 | 0.00785 |
dbNSFP
Source:
- Pathway
- RNA transport - Homo sapiens (human)
(Consensus)
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0269
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- NLS-bearing protein import into nucleus;positive regulation of GTPase activity
- Cellular component
- nucleus;nuclear pore;cytoplasm
- Molecular function
- GTPase activator activity;Ran GTPase binding